Skip to content
10-Q

Quarterly Report

AETERNUM HEALTH, INC. AETN

0001493152-23-037738

← back to feed
Filed
Oct 19, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Oct 9, 2023 48.48M sh
Shares Diluted Q2 2024 · Aug 31, 2023 48.17M sh
Shares Diluted Q2 2024 · Aug 31, 2023 47.69M sh
Shares Diluted Q2 2024 · Aug 31, 2022 8.85M sh
Shares Diluted Q2 2024 · Aug 31, 2022 8.85M sh
Operating Cash Flow Q2 2024 · Aug 31, 2023 −$192.38K
Operating Cash Flow restated Q2 2024 · Aug 31, 2022 −$123.68K
Stockholders Equity Q2 2024 · Aug 31, 2023 −$1.08M
Stockholders Equity Q2 2024 · May 31, 2023 −$966.61K
Stockholders Equity Q2 2024 · Feb 28, 2023 −$851.52K
Stockholders Equity restated Q2 2024 · Aug 31, 2022 −$1.56M
Stockholders Equity restated Q2 2024 · May 31, 2022 −$1.51M
Stockholders Equity restated Q2 2024 · Feb 28, 2022 −$1.41M
Current Liabilities Q2 2024 · Aug 31, 2023 $403.38K
Current Liabilities Q2 2024 · Feb 28, 2023 $343.48K
Total Liabilities Q2 2024 · Aug 31, 2023 $1.52M
Total Liabilities Q2 2024 · Feb 28, 2023 $1.53M
Current Assets Q2 2024 · Aug 31, 2023 $433.5K
Current Assets Q2 2024 · Feb 28, 2023 $675.27K
Total Assets Q2 2024 · Aug 31, 2023 $434.5K
Total Assets Q2 2024 · Feb 28, 2023 $676.27K
Eps Diluted Q2 2024 · Aug 31, 2023 $0.04
Eps Diluted Q2 2024 · Aug 31, 2023 $0.01
Eps Diluted restated Q2 2024 · Aug 31, 2022 $0.01
Eps Diluted restated Q2 2024 · Aug 31, 2022 $0.02
Eps Basic Q2 2024 · Aug 31, 2023 $0.04
Eps Basic Q2 2024 · Aug 31, 2023 $0.01
Eps Basic restated Q2 2024 · Aug 31, 2022 $0.01
Eps Basic restated Q2 2024 · Aug 31, 2022 $0.02
Sga Expense Q2 2024 · Aug 31, 2023 $9.73K
Sga Expense Q2 2024 · Aug 31, 2023 $64.04K
Sga Expense restated Q2 2024 · Aug 31, 2022 $10.76K
Sga Expense restated Q2 2024 · Aug 31, 2022 $22.79K
Net Income Q2 2024 · Aug 31, 2023 −$312.37K
Net Income Q2 2024 · Aug 31, 2023 −$427.46K
Net Income Q2 2024 · May 31, 2023 −$115.09K
Net Income restated Q2 2024 · Aug 31, 2022 −$52.67K
Net Income restated Q2 2024 · Aug 31, 2022 −$154.28K
Net Income Q2 2024 · May 31, 2022 −$101.6K
Operating Income Q2 2024 · Aug 31, 2023 −$281.93K
Operating Income Q2 2024 · Aug 31, 2023 −$380.97K
Operating Income restated Q2 2024 · Aug 31, 2022 −$52.67K
Operating Income restated Q2 2024 · Aug 31, 2022 −$108.21K
Gross Profit Q2 2024 · Aug 31, 2023 −$6.08K
Gross Profit Q2 2024 · Aug 31, 2023 −$6.66K
Gross Profit Q2 2024 · Aug 31, 2022 −$3.3K
Gross Profit Q2 2024 · Aug 31, 2022 −$10.95K
Cost Of Revenue Q2 2024 · Aug 31, 2023 $7.49K
Cost Of Revenue Q2 2024 · Aug 31, 2023 $18.38K
Cost Of Revenue Q2 2024 · Aug 31, 2022 $9.8K
Cost Of Revenue Q2 2024 · Aug 31, 2022 $20.5K
Revenue Q2 2024 · Aug 31, 2023 $2.53K
Revenue Q2 2024 · Aug 31, 2023 $11.72K
Revenue Q2 2024 · Aug 31, 2022 $6.51K
Revenue Q2 2024 · Aug 31, 2022 $9.55K